Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.

Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O'Neil PM, Perri MG, Pi-Sunyer FX, Rock CL, Erickson JS, Maier HN, Kim DD, Dunayevich E.

Obesity (Silver Spring). 2011 Jan;19(1):110-20. doi: 10.1038/oby.2010.147. Epub 2010 Jun 17.

2.

The efficacy and safety of the naltrexone/bupropion combination for the treatment of obesity: an update.

Christou GA, Kiortsis DN.

Hormones (Athens). 2015 Jul-Sep;14(3):370-5. doi: 10.14310/horm.2002.1600. Review.

3.

Contrave, a bupropion and naltrexone combination therapy for the potential treatment of obesity.

Padwal R.

Curr Opin Investig Drugs. 2009 Oct;10(10):1117-25. Review.

PMID:
19777400
4.

Naltrexone/bupropion for the treatment of obesity and obesity with Type 2 diabetes.

Apovian CM.

Future Cardiol. 2016 Mar;12(2):129-38. doi: 10.2217/fca.15.79. Epub 2015 Dec 18. Review.

PMID:
26679384
5.

Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'?

Katsiki N, Hatzitolios AI, Mikhailidis DP.

Ann Med. 2011 Jun;43(4):249-58. doi: 10.3109/07853890.2010.541490. Epub 2011 Jan 24. Review.

PMID:
21254901
6.

Combination therapy with naltrexone and bupropion for obesity.

Billes SK, Greenway FL.

Expert Opin Pharmacother. 2011 Aug;12(11):1813-26. doi: 10.1517/14656566.2011.591382. Epub 2011 Jun 21. Review.

PMID:
21689063
7.

Naltrexone ER/Bupropion ER: A Review in Obesity Management.

Greig SL, Keating GM.

Drugs. 2015 Jul;75(11):1269-80. doi: 10.1007/s40265-015-0427-5. Review.

PMID:
26105116
8.

Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity.

Ali KF, Shukla AP, Aronne LJ.

Expert Rev Clin Pharmacol. 2016;9(1):27-34. doi: 10.1586/17512433.2016.1100072. Epub 2015 Oct 29. Review.

PMID:
26512740
9.

Naltrexone/bupropion: Contrave(R); naltrexone SR/bupropion SR.

[No authors listed]

Drugs R D. 2010;10(1):25-32. doi: 10.2165/11537710-000000000-00000. Review.

10.

Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity.

Plodkowski RA, Nguyen Q, Sundaram U, Nguyen L, Chau DL, St Jeor S.

Expert Opin Pharmacother. 2009 Apr;10(6):1069-81. doi: 10.1517/14656560902775750 . Review.

PMID:
19364254
11.

Naltrexone/bupropion: an investigational combination for weight loss and maintenance.

Makowski CT, Gwinn KM, Hurren KM.

Obes Facts. 2011;4(6):489-94. doi: 10.1159/000335352. Epub 2011 Dec 15. Review.

12.

Drug safety evaluation of naltrexone/bupropion for the treatment of obesity.

Verpeut JL, Bello NT.

Expert Opin Drug Saf. 2014 Jun;13(6):831-41. doi: 10.1517/14740338.2014.909405. Epub 2014 Apr 28. Review.

PMID:
24766397
13.

Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.

Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S.

JAMA. 2016 Jun 14;315(22):2424-34. doi: 10.1001/jama.2016.7602. Review. Erratum in: JAMA. 2016 Sep 6;316(9):995.

PMID:
27299618
14.

Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss.

Billes SK, Sinnayah P, Cowley MA.

Pharmacol Res. 2014 Jun;84:1-11. doi: 10.1016/j.phrs.2014.04.004. Epub 2014 Apr 19. Review.

15.

Supplemental Content

Support Center